Rockwell Medical, Inc. (RMTI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
30142 WIXOM ROAD WIXOM, MI 48393 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 21,500 | 22,400 | 58,700 | 26,045 | 33,532 | 33,055 | |||
| Cash and cash equivalents | 10,102 | 13,280 | 48,682 | 11,795 | 22,714 | 8,407 | |||
| Short-term investments | 11,390 | 9,158 | 9,997 | 14,250 | 10,818 | 24,648 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 8 | (38) | 21 | ||||||
| Receivables | 6,259 | 5,913 | 4,171 | 4,203 | 7,351 | 6,356 | |||
| Inventory, net of allowances, customer advances and progress billings | 5,814 | 4,076 | 3,913 | 3,647 | 4,039 | 7,637 | |||
| Inventory | 5,814 | 4,076 | 3,913 | 3,647 | 4,039 | 7,637 | |||
| Other current assets | 1,780 | ||||||||
| Other undisclosed current assets | 1,737 | 2,899 | 2,685 | 2,980 | 1,904 | ||||
| Total current assets: | 35,310 | 35,288 | 69,469 | 36,874 | 46,825 | 48,828 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 1,276 | 1,523 | 1,176 | 441 | 1,637 | 5,987 | |||
| Finance lease, right-of-use asset, after accumulated amortization | ✕ | ✕ | |||||||
| Operating lease, right-of-use asset | 2,911 | 3,213 | ✕ | ✕ | |||||
| Property, plant and equipment | 2,194 | 2,486 | 2,642 | 2,433 | 2,638 | 2,549 | |||
| Intangible assets, net (including goodwill) | 921 | 921 | 921 | 921 | 921 | 925 | |||
| Goodwill | 921 | 921 | 921 | 921 | 921 | 921 | |||
| Intangible assets, net (excluding goodwill) | 4 | ||||||||
| Other noncurrent assets | 523 | 619 | 629 | 435 | 537 | 491 | |||
| Other undisclosed noncurrent assets | 6,411 | 7,737 | |||||||
| Total noncurrent assets: | 11,325 | 13,286 | 8,279 | 7,443 | 5,733 | 9,951 | |||
| TOTAL ASSETS: | 46,635 | 48,574 | 77,748 | 44,316 | 52,558 | 58,780 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 11,755 | 8,829 | 9,168 | 7,536 | 9,622 | 8,938 | |||
| Accounts payable | 4,053 | 3,739 | 4,155 | 3,018 | 4,492 | 4,222 | |||
| Accrued liabilities | 7,702 | 5,090 | 5,013 | 4,518 | 5,130 | 4,716 | |||
| Deferred revenue | 1,731 | 2,171 | 2,175 | 2,234 | ✕ | ✕ | |||
| Debt | 1,631 | 7,381 | 1,493 | ||||||
| Estimated litigation liability | 104 | 417 | |||||||
| Business combination, contingent consideration, liability | |||||||||
| Due to related parties | ✕ | 131 | 188 | 850 | |||||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 205 | ||
| Other undisclosed current liabilities | 2,574 | 2,585 | 1,319 | 819 | 2,316 | ||||
| Total current liabilities: | 17,691 | 20,966 | 12,793 | 12,374 | 13,205 | 9,143 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 7,555 | 13,186 | 22,770 | 1,781 | |||||
| Long-term debt, excluding current maturities | 7,555 | 13,186 | 20,949 | ||||||
| Finance lease, liability | ✕ | ✕ | |||||||
| Liabilities, other than long-term debt | 2,614 | 6,000 | 8,015 | 9,843 | 16,723 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 16,723 | ||
| Deferred revenue | 2,600 | 5,986 | 8,015 | 9,843 | ✕ | ✕ | |||
| Other liabilities | 14 | 14 | |||||||
| Operating lease, liability | 1,821 | 1,781 | ✕ | ✕ | |||||
| Business combination, contingent consideration, liability | |||||||||
| Other undisclosed noncurrent liabilities | 4,669 | 5,887 | 12,076 | ||||||
| Total noncurrent liabilities: | 14,838 | 25,073 | 30,785 | 11,623 | 12,076 | 16,723 | |||
| Total liabilities: | 32,529 | 46,039 | 43,578 | 23,997 | 25,281 | 25,866 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 14,106 | 2,535 | 34,170 | 20,320 | 27,277 | 32,913 | |||
| Additional paid in capital | 402,701 | 372,554 | 371,510 | 326,777 | |||||
| Accumulated other comprehensive income (loss) | 163 | 52 | 57 | 52 | 63 | (35) | |||
| Accumulated deficit | (388,759) | (370,080) | (337,406) | (306,516) | (272,388) | (240,262) | |||
| Other undisclosed equity, attributable to parent | 1 | 9 | 9 | 7 | 299,602 | 273,211 | |||
| Total equity: | 14,106 | 2,535 | 34,170 | 20,320 | 27,277 | 32,913 | |||
| TOTAL LIABILITIES AND EQUITY: | 46,635 | 48,574 | 77,748 | 44,316 | 52,558 | 58,780 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 72,810 | 61,931 | 62,197 | 61,303 | 63,389 | 57,300 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 57,300 | |
| Cost of revenue (Cost of Goods and Services Sold) | (68,733) | (64,351) | (59,472) | (58,464) | (64,973) | (53,598) | ||
| Gross profit: | 4,077 | (2,420) | 2,725 | 2,839 | (1,585) | 3,702 | ||
| Operating expenses | (20,857) | (27,916) | (31,145) | (37,364) | (29,755) | (29,625) | ||
| Other undisclosed operating loss | (1,100) | |||||||
| Operating loss: | (16,780) | (30,336) | (28,420) | (34,525) | (32,439) | (25,923) | ||
| Nonoperating income (expense) | (1,899) | (2,338) | (2,470) | 397 | 313 | 2 | ||
| Investment income, nonoperating | 1 | |||||||
| Gain, foreign currency transaction, before tax | 1 | |||||||
| Other nonoperating income (expense) | (1,899) | (2,338) | (2,470) | 397 | 313 | |||
| Interest and debt expense | (1,936) | (2,360) | (1,879) | |||||
| Loss from continuing operations: | (20,615) | (35,034) | (32,769) | (34,128) | (32,126) | (25,921) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (35,034) | (32,769) | (34,128) | (32,126) | (25,921) | |
| Net loss: | (20,615) | (35,034) | (32,769) | (34,128) | (32,126) | (25,921) | ||
| Other undisclosed net income attributable to parent | 1,936 | 2,360 | 1,879 | |||||
| Net loss available to common stockholders, diluted: | (18,679) | (32,674) | (30,890) | (34,128) | (32,126) | (25,921) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (20,615) | (35,034) | (32,769) | (34,128) | (32,126) | (25,921) | ||
| Comprehensive loss: | (20,615) | (35,034) | (32,769) | (34,128) | (32,126) | (25,921) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2,047 | 2,355 | 1,884 | (11) | 99 | 867 | ||
| Comprehensive loss, net of tax, attributable to parent: | (18,568) | (32,679) | (30,885) | (34,139) | (32,027) | (25,054) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.